1. Patient 'candidate' for thrombolysis: MRI is essential
- Author
-
Charles Mellerio, J.-F. Meder, Catherine Oppenheim, Stéphanie Lion, Christine Rodriguez-Régent, C.-F. Jbanca, Laurence Legrand, Marie Tisserand, R Souillard-Scemama, Olivier Naggara, Myriam Edjlali, and Denis Trystram
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Sensitivity and Specificity ,Brain Ischemia ,Brain ischemia ,Penumbra ,Image Interpretation, Computer-Assisted ,Occlusion ,medicine ,Perfusion-weighted imaging ,Humans ,Thrombolytic Therapy ,Radiology, Nuclear Medicine and imaging ,Stroke ,Radiological and Ultrasound Technology ,Cerebral infarction ,business.industry ,Patient Selection ,food and beverages ,Cerebral Infarction ,General Medicine ,Thrombolysis ,Middle Aged ,Image Enhancement ,Prognosis ,medicine.disease ,Arterial Ischemic Stroke ,Diffusion Magnetic Resonance Imaging ,Female ,Diffusion-weighted imaging ,Radiology ,Artifacts ,business ,Arterial ischemic stroke ,Diffusion MRI - Abstract
Because of its excellent sensitivity and specificity to diagnose arterial ischemic stroke (AIS) in the acute phase, MRI answers the main questions to guide treatment in “candidates” for thrombolysis. It lasts less than ten minutes, can confirm the diagnosis of AIS and distinguish it from hematomas and other “stroke mimics”. It can identify the ischemic penumbra (perfusion-diffusion mismatch), determine the site of occlusion and provide prognostic information to adapt treatment in some cases in which the indications are poorly defined. In light of the most recent scientific findings, MRI can guide the treatment turning it into the investigation of choice in “candidates” for thrombolysis.
- Published
- 2014
- Full Text
- View/download PDF